Published in Cancer Epidemiol Biomarkers Prev on December 01, 2009
Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med (2012) 2.72
US smokers' reactions to a brief trial of oral nicotine products. Harm Reduct J (2011) 1.32
Nicotine reduction: strategic research plan. Nicotine Tob Res (2012) 1.27
Conference on abuse liability and appeal of tobacco products: conclusions and recommendations. Drug Alcohol Depend (2011) 1.09
Measures for assessing subjective effects of potential reduced-exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Relationship of cigarette-related perceptions to cigarette design features: findings from the 2009 ITC U.S. Survey. Nicotine Tob Res (2013) 1.03
Tobacco and nicotine product testing. Nicotine Tob Res (2011) 0.96
The impact of product information and trials on demand for smokeless tobacco and cigarettes: evidence from experimental auctions. Prev Med (2013) 0.89
Postmarketing surveillance for "modified-risk" tobacco products. Nicotine Tob Res (2011) 0.88
Subjective responses to oral tobacco products: scale validation. Nicotine Tob Res (2012) 0.81
Reduced Nicotine Content Expectancies Affect Initial Responses to Smoking. Tob Regul Sci (2016) 0.77
US Smokers' Beliefs, Experiences and Perceptions of Different Cigarette Variants Before and After the FSPTCA Ban on Misleading Descriptors Such as "Light," "Mild," or "Low". Nicotine Tob Res (2016) 0.77
Providing a Science Base for the Evaluation of Tobacco Products. Tob Regul Sci (2015) 0.76
Using Electrophysiological Measures to Assess the Consumer Acceptability of Smokeless Tobacco Products. Nicotine Tob Res (2016) 0.75
Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry (1986) 10.11
Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents. Tob Control (2002) 5.86
The development and initial validation of a questionnaire on smoking urges. Br J Addict (1991) 4.77
New challenges for telephone survey research in the twenty-first century. Annu Rev Public Health (2007) 4.43
The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact. Tob Control (2002) 4.05
Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob Res (2007) 2.12
Design effects in the transition to web-based surveys. Am J Prev Med (2007) 2.01
Open source marketing: Camel cigarette brand marketing in the "Web 2.0" world. Tob Control (2009) 2.00
Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med (2005) 1.90
Effect of health messages about "Light" and "Ultra Light" cigarettes on beliefs and quitting intent. Tob Control (2001) 1.76
What do Marlboro Lights smokers know about low-tar cigarettes? Nicotine Tob Res (2004) 1.70
Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products. Nicotine Tob Res (2004) 1.53
Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tob Control (2000) 1.51
Methods to assess potential reduced exposure products. Nicotine Tob Res (2005) 1.36
The role of sensory perception in the development and targeting of tobacco products. Addiction (2007) 1.35
Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tob Control (2007) 1.30
Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications. Nicotine Tob Res (2007) 1.27
What motivates adolescent smokers to make a quit attempt? Drug Alcohol Depend (2002) 1.24
Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal. Pharmacol Biochem Behav (1997) 1.22
New tobacco products: do smokers like them? Tob Control (2006) 1.21
Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes. Psychol Addict Behav (2006) 1.15
Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance. Tob Control (2003) 1.04
Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine Tob Res (2000) 1.02
Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting. Nicotine Tob Res (2002) 1.02
Consumer awareness and attitudes related to new potential reduced-exposure tobacco products. Am J Health Behav (2007) 1.00
Assessing internal tobacco industry knowledge of the neurobiology of tobacco dependence. Nicotine Tob Res (2004) 0.99
College students' expectancies for light cigarettes and potential reduced exposure products. Am J Health Behav (2007) 0.97
Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products. Tob Control (2007) 0.94
Findings and implications from a national study on potential reduced exposure products (PREPs). Nicotine Tob Res (2006) 0.93
Subjective and discriminative stimulus effects of two de-nicotinized cigarettes with different tar yields. Nicotine Tob Res (2001) 0.92
What do adult smokers think about ads and promotional materials for PREPs? Am J Health Behav (2007) 0.92
Ever users versus never users of a "less risky" cigarette. Psychol Addict Behav (2005) 0.89
Puffing style and human exposure minimally altered by switching to a carbon-filtered cigarette. Cancer Epidemiol Biomarkers Prev (2008) 0.87
Individual differences in relative hemispheric alpha abundance and cognitive responses to persuasive communications. J Pers Soc Psychol (1982) 0.83
Physical design analysis and mainstream smoke constituent yields of the new potential reduced exposure product, Marlboro UltraSmooth. Nicotine Tob Res (2007) 0.80
Lower nicotine cigarettes may not lower harm. LDI Issue Brief (2007) 0.77
Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med (2013) 6.35
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
How reactions to cigarette packet health warnings influence quitting: findings from the ITC Four-Country survey. Addiction (2009) 5.37
Text and graphic warnings on cigarette packages: findings from the international tobacco control four country study. Am J Prev Med (2007) 5.05
Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health (2010) 4.21
Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest (2011) 3.87
The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev (2004) 3.80
Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res (2004) 3.78
Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med (2015) 3.63
Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet (2005) 3.29
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction (2010) 3.26
A longitudinal assessment of the impact of smoke-free worksite policies on tobacco use. Am J Public Health (2005) 3.05
Electronic cigarettes: a new 'tobacco' industry? Tob Control (2010) 2.95
Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res (2004) 2.89
Electronic cigarettes: the tobacco industry's latest threat to oral health? J Am Dent Assoc (2015) 2.81
Smoking at diagnosis and survival in cancer patients. Int J Cancer (2012) 2.76
Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med (2012) 2.72
Epidemiology of menthol cigarette use. Nicotine Tob Res (2004) 2.66
The near-universal experience of regret among smokers in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Nicotine Tob Res (2004) 2.63
Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev (2005) 2.59
Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res (2012) 2.54
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol (2009) 2.52
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther (2006) 2.49
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Designing cigarettes for women: new findings from the tobacco industry documents. Addiction (2005) 2.40
Access to low-taxed cigarettes deters smoking cessation attempts. Am J Public Health (2005) 2.33
Cigarette purchasing behaviors when prices are high. J Public Health Manag Pract (2005) 2.33
Attitudes and beliefs about secondhand smoke and smoke-free policies in four countries: findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res (2009) 2.30
Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys. Tob Control (2009) 2.29
Secondhand smoke transfer in multiunit housing. Nicotine Tob Res (2010) 2.27
Most smokeless tobacco use is not a causal gateway to cigarettes: using order of product use to evaluate causation in a national US sample. Addiction (2003) 2.26
New cigarette brands with flavors that appeal to youth: tobacco marketing strategies. Health Aff (Millwood) (2005) 2.22
The impact of cigarette pack design, descriptors, and warning labels on risk perception in the U.S. Am J Prev Med (2011) 2.18
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst (2008) 2.17
Use of and beliefs about light cigarettes in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Nicotine Tob Res (2004) 2.14
Tobacco outlet density and demographics in Erie County, New York. Am J Public Health (2003) 2.14
How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction (2012) 2.13
Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob Res (2007) 2.12
Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine Tob Res (2010) 2.10
How did UK cigarette makers reduce tar to 10 mg or less? BMJ (2006) 2.10
Eclipse: does it live up to its health claims? Tob Control (2002) 2.08
Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav (2013) 2.07
Socio-economic variation in price minimizing behaviors: findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health (2011) 2.06
Marketing little cigars and cigarillos: advertising, price, and associations with neighborhood demographics. Am J Public Health (2013) 2.02
Use of flavored cigarettes among older adolescent and adult smokers: United States, 2004--2005. Nicotine Tob Res (2008) 2.01
A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control (2012) 2.00
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst (2004) 1.99
The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res (2008) 1.98
Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.97
Using a telephone survey to acquire genetic and behavioral data related to cigarette smoking in "made-anonymous" and "registry" samples. Am J Epidemiol (2002) 1.92
Trends in the use of cigarettes and other tobacco products, 2000-2007. JAMA (2008) 1.92
Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med (2005) 1.90
Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr (2004) 1.90
Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol (2009) 1.89
Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev (2008) 1.87
Tobacco industry control of menthol in cigarettes and targeting of adolescents and young adults. Am J Public Health (2008) 1.85
The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics (2006) 1.83
Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev (2009) 1.82
Concern about security and privacy, and perceived control over collection and use of health information are related to withholding of health information from healthcare providers. J Am Med Inform Assoc (2013) 1.82
Beyond light and mild: cigarette brand descriptors and perceptions of risk in the International Tobacco Control (ITC) Four Country Survey. Addiction (2011) 1.79
Measuring air quality to protect children from secondhand smoke in cars. Am J Prev Med (2006) 1.78
Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev (2005) 1.77
Apply federal research rules on deception to misleading health information: an example on smokeless tobacco and cigarettes. Public Health Rep (2003) 1.77
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev (2005) 1.76
Multiunit housing residents' experiences and attitudes toward smoke-free policies. Nicotine Tob Res (2010) 1.76
Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol (2012) 1.74
Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74
The etiology of alcohol-induced breast cancer. Alcohol (2005) 1.73
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand. Addiction (2012) 1.70
Youth access, creation, and content of smokeless tobacco ("dip") videos in social media. J Adolesc Health (2011) 1.70
Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev (2007) 1.66
How smoke-free laws improve air quality: a global study of Irish pubs. Nicotine Tob Res (2009) 1.66
Impact of the removal of misleading terms on cigarette pack on smokers' beliefs about 'light/mild' cigarettes: cross-country comparisons. Addiction (2011) 1.64
The impact of smokefree legislation in Scotland: results from the Scottish ITC: Scotland/UK longitudinal surveys. Eur J Public Health (2009) 1.60
How do price minimizing behaviors impact smoking cessation? Findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health (2011) 1.59
What is eHealth (6): perspectives on the evolution of eHealth research. J Med Internet Res (2006) 1.57
Views on smoking cessation methods in ethnic minority communities: a qualitative investigation. Prev Med (2006) 1.57
Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol (2006) 1.55
Application, function, and effects of menthol in cigarettes: a survey of tobacco industry documents. Nicotine Tob Res (2004) 1.54
Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products. Nicotine Tob Res (2004) 1.53
Lifetime cumulative exposure to secondhand smoke and risk of myocardial infarction in never smokers: results from the Western New York health study, 1995-2001. Arch Intern Med (2006) 1.51
Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control (2010) 1.51
Early evidence on the effectiveness of clean indoor air legislation in New York State. Am J Public Health (2005) 1.50
Reduction in amount smoked predicts future cessation. Psychol Addict Behav (2005) 1.50
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
Making smoking history worldwide. N Engl J Med (2007) 1.49
Smoke-free homes and smoking cessation and relapse in a longitudinal population of adults. Nicotine Tob Res (2009) 1.49
Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem Res Toxicol (2007) 1.49
Revising the machine smoking regime for cigarette emissions: implications for tobacco control policy. Tob Control (2007) 1.46